TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Keryx Biopharmaceuticals (NASDAQ: KERX) Investor Securities Class Action Lawsuit 08/02/2016

  • If you purchased shares of Keryx Biopharmaceuticals (NASDAQ: KERX), you might have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

April 13, 2017 - The case was transferred to the U.S. District Court for the District of Massachusetts. October 3, 2016 - Lead plaintiff motions were filed. August 2, 2016 - An investor in shares of Keryx Biopharmaceuticals (NASDAQ: KERX) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Keryx Bioph...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: